自动化腹部CT影像生物标志物与临床衰弱评估同死后供体肝移植术后结局的关联
回顾性纳入2005至2021年598例首次死后供体肝移植受者,用AI体成分工具分析移植前腹部CT,并结合Fried衰弱评分,评估其预测术后死亡与移植物失败的价值;结果显示肝体积增大、腹主动脉Agatston评分升高、骨骼肌衰减减低及皮下脂肪面积减小与术后死亡风险升高相关,CT指标与临床衰弱评估具有互补性。
要点
- 移植前CT肝体积、腹主动脉Agatston评分、骨骼肌衰减及皮下脂肪面积与肝移植术后死亡风险相关。
- 满足衰弱标准者年龄性别校正HR为2.14(95%CI 1.08-4.22)。
- 肝体积、腹主动脉Agatston评分与肌肉衰减联合预测10年死亡的AUC为0.675。
核心结论
- 全自动CT测量的肌肉密度(肌脂肪变)、主动脉钙化、皮下脂肪和肝体积可预测肝移植受者死亡,衰弱的预测作用同样存在,CT与临床衰弱评估具有互补性。
研究设计与样本
- 回顾性队列研究,纳入2005至2021年598例首次死后供体肝移植受者(中位年龄56岁,IQR 49-61;男383例、女215例)。
- 对移植前腹部CT应用AI体成分工具,临床衰弱数据(Fried衰弱评分)取自既有移植数据库。
- 按最高风险四分位与其他三个四分位合并比较,分析年龄和性别校正的风险比,并行单因素与多因素ROC AUC分析。
关键影像表现/征象
- CT测量的体成分为肝体积、腹主动脉Agatston评分、骨骼肌衰减和皮下脂肪面积,原文未描述具体影像征象细节。
诊断标准与关键数值
- 术后生存的单因素HR:肌肉衰减1.53(95%CI 1.14-2.06)、腹主动脉Agatston评分1.66(95%CI 1.24-2.22)、皮下脂肪面积1.35(95%CI 1.02-1.80)、肝体积1.82(95%CI 1.35-2.46)。
- 满足衰弱标准者HR为2.14(95%CI 1.08-4.22)。
- 以肝体积、腹主动脉Agatston评分和肌肉衰减预测死亡的多因素10年AUC为0.675。
- 临床衰弱评估的10年单因素AUC为0.601,与CT指标联合后升至0.878。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To quantify the potential of fully automated CT-based body composition metrics and clinical frailty data in predicting liver transplant recipient postoperative outcomes.
METHODS: AI-enabled body composition tools were applied to pre-transplant abdominal CT scans in a retrospective cohort of first-time deceased-donor liver transplant recipients. Clinical frailty data (Fried frailty score) was obtained from an established transplant database. Age- and sex-corrected hazard ratios (HRs) were analyzed according to highest-risk quartiles compared with the other three quartiles combined. Area under the receiver operating characteristic curve (ROC AUC) analysis in univariate and multivariate scenarios was also performed.
RESULTS: 598 liver transplant recipients (median age, 56 years [IQR, 49-61]; 383 men/215 women) were included from 2005 to 2021. Mean clinical follow-up interval after transplant was 8.6 ± 4.5 years, with 224 deaths (mean interval, 5.3 ± 3.9 years post-transplant) and 246 graft failures (mean interval, 4.7 ± 4.0 years post-transplant) observed. Univariate HRs for post-transplant survival included 1.53 (95% CI, 1.14-2.06) for muscle attenuation, 1.66 (95% Cl, 1.24-2.22) for aortic Agatston score, 1.35 (1.02-1.80) for SAT area, and 1.82 (1.35-2.46) for liver volume. For those meeting the frailty criteria, HR was 2.14 (1.08-4.22). Multivariate 10-year AUC for predicting mortality was 0.675 using liver volume, aortic Agatston score, and muscle attenuation. 10-year univariate AUC for clinical frailty assessment was 0.601 but increased to 0.878 when combined with CT measures.
CONCLUSION: Automated CT measurements of muscle density (myosteatosis), aortic calcification, subcutaneous fat, and liver volume are predictive of mortality in liver transplant recipients. Frailty was likewise predictive. Combining CT and clinical frailty assessment was complementary.
KEY POINTS: Question What is the prognostic value of pre-transplant CT-based body composition measures for deceased-donor liver transplant outcomes, and how do they correlate with frailty assessment? Findings Increased post-transplant mortality was associated with pre-transplant increased liver volume, increased abdominal aortic Agatston score, decreased skeletal muscle attenuation, and decreased subcutaneous adipose tissue area. Clinical relevance Pre-transplant AI-enabled body composition measures have predictive value for post-transplant survival, offering a novel and objective diagnostic tool to identify high-risk transplant recipients that are complementary to clinical assessments.
引用
- Liu D, Ji D, Garrett JW, et al. Automated abdominal CT imaging biomarkers and clinical frailty measures associated with postoperative deceased-donor liver transplant outcomes. Eur Radiol. 2025. PMID: 40121592. doi:10.1007/s00330-025-11523-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。